Sequenom, Inc. (SQNM)
$3.13
0.03 (+0.97%)
| CAPS Rating |
|
|---|---|
| Open | $3.13 |
| Previous Close | $3.10 |
| Daily Range | $3.10 - $3.18 |
| 52-Week Range | $2.55 - $25.99 |
| Market Cap | $191.71M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,275,997 |
| Average Daily Volume | 2,957,000 |
How do you think SQNM will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
SQNM Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
SQNM News and Commentary
- 4-Star Stocks on the Upswing – The Motley Fool
- UPDATE 1-Sequenom posts wider Q3 net loss; shares down – Reuters
- Seeking Alpha on Sequenom, Inc. – Ockham-RazorWire
- Fearful Stocks for Greedy Investors – The Motley Fool
- Fearful Stocks for Greedy Investors – The Motley Fool
- UPDATE 1-Sequenom says Nasdaq, US Attorney enquires about probe – Reuters
- Tomorrow's Monster Stock? – The Motley Fool
- 3 Stocks in a Tailspin – The Motley Fool
- Call Me a Wimp, but I'm Still Nervous – The Motley Fool
- Is SQNM a good buy today @ $3.24 ?? It's down 43% in after trade.. – Blog at The Motley Fool
- SQNM crashed in after trade hours – Blog at The Motley Fool
- UPDATE 1-Sequenom fires CEO on Down Syndrome test investigation – Reuters
- 5 Stocks Approaching Greatness – The Motley Fool
- Hey, Sequenom, That's Great, But ... – The Motley Fool
- Sequenom launches cystic fibrosis screening test, shares rise – Reuters
- To hell with it – Blog at The Motley Fool
- Stock Smackdown: Cramer vs. CAPS – The Motley Fool
- Recent trades in my RL portfolio – Blog at The Motley Fool
- These 5 Underdogs Are No Dogs – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool


RSS Headlines
Fool UK